Pipeline Lundbeck to present new Vyepti and bocunebart data at EAN 2026 PharmaTimesLundbeck will present new migraine data at the European Academy of Neurology Congress 2026, taking place from 27-30 June in Geneva.NeuroscienceRead full story pharminent June 24, 2026 (Last updated: June 24, 2026) PharmaTimes Lundbeck will present new migraine data at the European Academy of Neurology Congress 2026, taking place from 27-30 June in Geneva. Neuroscience Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: URA and Lilly join forces to harmonise drug-wearable obesity careNext: SK pharmteco Launches SKyvec Viral Vector Platform for Gene Therapy Related Stories Pipeline AAIC 2026: Tau-targeted Alzheimer’s treatments heat up while amyloid therapies persist pharminent July 10, 2026 Pipeline Roche scraps two Ionis-partnered Huntington’s drugs pharminent July 9, 2026 Pipeline Keenova eyes Xiaflex as first drug for plantar fibromatosis pharminent July 9, 2026
